dario.olivero – Pagina 30 – AMD

dario.olivero

Dicembre 14, 2023 dario.olivero

Continuous glucose monitoring systems in non-insulin-treated people with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials

Oliva Morgado Ferreira R, Trevisan T, Pasqualotto E, et al.
Diabetes Technology & Therapeutics. Pub. online 13 Dec 2023.

Leggi

Dicembre 14, 2023 dario.olivero

Increased circulating FGF21 level predicts the burden of metabolic demands and risk of vascular diseases in adults with type 2 diabetes

Liu Z, Peng Y, Li S, et al.
BMC Endocr Disord. 2023;23(1):272.

Leggi

Dicembre 11, 2023 dario.olivero

Occurrence of gastrointestinal adverse events upon glp-1 receptor agonist initiation with concomitant metformin use: a post hoc analysis of LEADER, STEP 2, SUSTAIN 6, and PIONEER 6

Klein KR, Clemmensen KKB, Fong E, et al.
Diabetes Care. 2023:dc231791.

Leggi

Dicembre 11, 2023 dario.olivero

Effect of the dual sodium‐glucose co‐transporter‐1 and ‐2 inhibitor sotagliflozin on renal outcomes in type 1 diabetes and type 2 diabetes: A systematic review and meta‐analysis of randomized controlled trials

Bantounou MA, Sardellis P, Thuemmler R, et al.
Diabetes Obes Metab. Pub. online 29 Nov 2023.

Leggi

Dicembre 11, 2023 dario.olivero

Patterns of telemedicine use and glycemic outcomes of endocrinology care for patients with type 2 diabetes

Zupa MF, Vimalananda VG, Rothenberger SD, et al.
JAMA Netw Open. 2023;6(12):e2346305.

Leggi

Dicembre 7, 2023 dario.olivero

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

The EMPA-KIDNEY Collaborative Group
The Lancet Diabetes & Endocrinology. Pub. online 4 Dec 2023.

Leggi

Dicembre 7, 2023 dario.olivero

Efficacy and safety of bempedoic acid among patients with and without diabetes: prespecified analysis of the CLEAR Outcomes randomised trial

Ray KK, Nicholls SJ, Li N, et al.
The Lancet Diabetes & Endocrinology. Pub. online 4 Dec 2023.

Leggi

Dicembre 7, 2023 dario.olivero

Use of voice-based conversational artificial intelligence for basal insulin prescription management among patients with type 2 diabetes: a randomized clinical trial

Nayak A, Vakili S, Nayak K, et al.
JAMA Netw Open. 2023;6(12):e2340232.

Leggi

Dicembre 7, 2023 dario.olivero

Dyslipidaemia as a target for atherosclerotic cardiovascular disease prevention in children with type 1 diabetes: lessons learned from familial hypercholesterolaemia

Corpeleijn WE, de Waal WJ, Schipper HS, Wiegman A
Diabetologia. Pub. online 30 Nov 2023.

Leggi

Dicembre 7, 2023 dario.olivero

The association between glycemic index, glycemic load and total carbohydrate intake and risk of premature coronary artery disease: Iran Premature Coronary Artery: disease study (IPAD): a case-control study

Nurizadeh F, Mohamadifard N, Nouri F, et al.
Nutrition, Metabolism and Cardiovascular Diseases. Pub. online 27 Nov 2023.

Leggi